Podcast
Play an AI-generated podcast conversation about this lesson
Questions and Answers
What is the primary outcome measured in this study?
What is the primary outcome measured in this study?
- Mean change in hemoglobin A1c (HbA1c) (correct)
- Mean change in postprandial blood glucose (PPBG)
- Mean change in body weight
- Mean change in fasting blood glucose (FBG)
How many participants were randomly assigned to receive either of the treatment regimens?
How many participants were randomly assigned to receive either of the treatment regimens?
- 256 participants
- 276 participants
- 236 participants (correct)
- 200 participants
What is the duration of this clinical study?
What is the duration of this clinical study?
- 20 weeks
- 24 weeks
- 16 weeks
- 18 weeks (correct)
What is the dosing regimen for dapagliflozin in both combination therapies?
What is the dosing regimen for dapagliflozin in both combination therapies?
Signup and view all the answers
Which combination therapy showed a more significant reduction in HbA1c compared to the other?
Which combination therapy showed a more significant reduction in HbA1c compared to the other?
Signup and view all the answers
What is the target HbA1c level achieved by some participants in this study?
What is the target HbA1c level achieved by some participants in this study?
Signup and view all the answers
Flashcards are hidden until you start studying
